Clinical Trial Update: Dual Therapy With Boosted Darunavir + Dolutegravir [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on boosted darunavir plus dolutegravir for HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• boosted darunavir + dolutegravir

Snippet

Sponsor: Technical University of Munich | Conditions: HIV-Infection | Phase 3 | Status: COMPLETED